SCHEMBL11943178

SCHEMBL11943178

Cc1cc(S(=O)(=O)N2CCN(c3cnn(-c4ccccc4)c(=O)c3N3CCN(C)CC3)CC2)c(C)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.55
▸ DCTPP1 Q9H773 2/20 0.53
▸ MAPT P10636 2/20 0.52
▸ POLB P06746 4/20 0.52
▸ LMNA P02545 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ GAA P10253 1/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ PPARG P37231 1/20 0.44
▸ NCOA2 Q15596 1/20 0.44
▸ NCOA1 Q15788 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ NCOA3 Q9Y6Q9 1/20 0.44
▸ PKM P14618 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13329124 0.93 POLB (0.54) ALDH1A1DCTPP1MAPTPOLBLMNA
SCHEMBL11943201 0.81 POLB (0.53) ALDH1A1DCTPP1MAPTPOLBLMNA
SCHEMBL11943206 0.80 KMT2A (0.53) ALDH1A1DCTPP1MAPTPOLBLMNA
SCHEMBL11943299 0.80 POLB (0.57) ALDH1A1DCTPP1MAPTPOLBLMNA
SCHEMBL11943288 0.79 LMNA (0.60) ALDH1A1DCTPP1MAPTPOLBLMNA
SCHEMBL11943283 0.78 MAPT (0.60) ALDH1A1DCTPP1MAPTPOLBLMNA
SCHEMBL11943312 0.78 ALDH1A1 (0.51) ALDH1A1DCTPP1MAPTPOLBLMNA
SCHEMBL11943314 0.77 ALDH1A1 (0.52) ALDH1A1DCTPP1MAPTPOLBLMNA
SCHEMBL13328760 0.77 LMNA (0.53) ALDH1A1DCTPP1MAPTPOLBLMNA
SCHEMBL13304476 0.76 SMN1; SMN2 (0.65) ALDH1A1DCTPP1MAPTPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-20100158992-A1 PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS SCHERING CORPORATION (US) 2010-06-24 — — US disclosed
US-20100158992-A1 PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS SCHERING CORPORATION (US) 2010-06-24 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors MAN2A1, GYS2, MANBA ALDH1A1 2437/4885DCTPP1 625/4885MAPT 2295/4885
US-20100158992-A1 PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS DPM1, GMPS, MAN2A1 ALDH1A1 2003/4885DCTPP1 209/4885MAPT 3651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback